Estrella Immunopharma- Warrants (29/09/2028) Net Tangible Assets

Estrella Immunopharma- Warrants (29/09/2028) (ESLAW) currently reports a net tangible assets of $-7.4M as of June 2026. That compares with $-6.1M in the prior-year period — down 21.9% year over year. Use the charts on this page to explore Estrella Immunopharma- Warrants (29/09/2028)'s net tangible assets history and peer comparisons.

Estrella Immunopharma- Warrants (29/09/2028)'s net tangible assets decreased from $-6.1M to $-7.4M — a 21.9% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Estrella Immunopharma- Warrants (29/09/2028) reported $-7.4M in net tangible assets as of June 2026. That compares with $-6.1M in the prior-year period — down 21.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current net tangible assets of $-7.4M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Estrella Immunopharma- Warrants (29/09/2028), and consider following ESLAW for alerts when major investors trade the stock.